Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
ANZ Journal of Surgery
|
October 8, 2025
Weight Loss Outcomes Following Government-Funded Conversion Gastric Bypass: Roux-en-Y Versus One-Anastomosis-Does the Type of Bypass Matter?
Chiara Chadwick, George Hopkins, Zoe Jarrott, et al.
Diseases of the Colon and Rectum
|
October 18, 2005
Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case
Robert Finch, Harvey G Moore, Noralane Lindor, et al.
JCO Precision Oncology
|
May 15, 2024
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer
Jonathan D Tward, Lauren Lenz, Alexander Gutin, et al.
The American Journal of Gastroenterology
|
November 12, 2002
Autosomal dominant infantile gastroesophageal reflux disease: exclusion of a 13q14 locus in five well characterized families
Susan R Orenstein, Theresa M Shalaby, Robert Finch, et al.
Annals of Surgical Oncology
|
September 30, 2006
Hepatic resection for colorectal metastasis: impact of tumour size
Zaed Z R Hamady, Hassan Z Malik, Robert Finch, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
May 2, 2015
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers
Matthew E Burge, Nick O'Rourke, David Cavallucci, et al.
Future Oncology (London, England)
|
June 16, 2026
Development and validation of a digital pathology artificial intelligence (DPAI)-derived risk score predicting Gleason grade group reclassification for patients who are candidates for active surveillance
Brent Mabey, Lauren H Lenz, Matthew J Schiewer, et al.
Prostate Cancer and Prostatic Diseases
|
September 5, 2024
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing
Lauren Lenz, Wyatt Clegg, Diana Iliev, et al.
European Urology Open Science
|
April 17, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry
Steven M Monda, Eugene Oh, Patrick J Lewicki, et al.
The Prostate
|
March 3, 2022
Hereditary cancer risk assessment and genetic testing in the community urology practice setting
Neal D Shore, Lauren Lenz, Elizabeth S Cogan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
ANZ Journal of Surgery
|
October 8, 2025
Weight Loss Outcomes Following Government-Funded Conversion Gastric Bypass: Roux-en-Y Versus One-Anastomosis-Does the Type of Bypass Matter?
Chiara Chadwick, George Hopkins, Zoe Jarrott, et al.
Diseases of the Colon and Rectum
|
October 18, 2005
Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case
Robert Finch, Harvey G Moore, Noralane Lindor, et al.
JCO Precision Oncology
|
May 15, 2024
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer
Jonathan D Tward, Lauren Lenz, Alexander Gutin, et al.
The American Journal of Gastroenterology
|
November 12, 2002
Autosomal dominant infantile gastroesophageal reflux disease: exclusion of a 13q14 locus in five well characterized families
Susan R Orenstein, Theresa M Shalaby, Robert Finch, et al.
Annals of Surgical Oncology
|
September 30, 2006
Hepatic resection for colorectal metastasis: impact of tumour size
Zaed Z R Hamady, Hassan Z Malik, Robert Finch, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
May 2, 2015
A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers
Matthew E Burge, Nick O'Rourke, David Cavallucci, et al.
Future Oncology (London, England)
|
June 16, 2026
Development and validation of a digital pathology artificial intelligence (DPAI)-derived risk score predicting Gleason grade group reclassification for patients who are candidates for active surveillance
Brent Mabey, Lauren H Lenz, Matthew J Schiewer, et al.
Prostate Cancer and Prostatic Diseases
|
September 5, 2024
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing
Lauren Lenz, Wyatt Clegg, Diana Iliev, et al.
European Urology Open Science
|
April 17, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing Registry
Steven M Monda, Eugene Oh, Patrick J Lewicki, et al.
The Prostate
|
March 3, 2022
Hereditary cancer risk assessment and genetic testing in the community urology practice setting
Neal D Shore, Lauren Lenz, Elizabeth S Cogan, et al.
Page
of 3